查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1931246

全球侵入式餵食管市场（按管型、材质、最终用户、年龄层和分销管道划分）预测（2026-2032年）

Invasive Feeding Tube Market by Tube Type, Material, End User, Age Group, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，侵入性肠内营养管市场价值将达到 18.5 亿美元，到 2026 年将成长至 19.4 亿美元，到 2032 年将达到 26.8 亿美元，复合年增长率为 5.40%。

关键市场统计数据
基准年 2025 18.5亿美元
预计年份：2026年 19.4亿美元
预测年份 2032 26.8亿美元
复合年增长率 (%) 5.40%

本书全面介绍了侵入性鼻饲管技术、临床决策路径以及影响患者预后的跨专业连续性照护。

本执行摘要概述了侵入性餵食管的现状，并将其置于现代医疗保健服务体系中，涵盖了技术、临床适应症和相关人员的责任等方面。摘要首先概述了器械类型和材质，重点介绍了选择肠内营养途径的临床情况，并阐明了从外科医生到居家照护协调员等多学科团队的角色。预先建立这些基础知识，能够帮助读者快速了解器械特性、手术选择和病人预后之间的关联。

临床、材料和护理服务的变革性变化正在重新定义经肠营养程序的选择、设备设计重点和医疗服务提供者的采购行为。

在临床创新、监管力度加大以及医疗服务模式变革的推动下，侵入性餵食管领域正经历变革性的转变。微创技术和器材人体工学设计的进步，使得胃造瘻术和空肠造瘻术在各种医疗环境中都更加安全便捷。同时，聚氨酯和硅胶等材料的改进，也解决了生物相容性和耐用性方面的问题。此外，对以患者为中心的治疗效果的日益重视，正在加速推广那些强调降低併发症发生率和实现从医院到居家照护平稳过渡的通讯协定。

2025年美国关税调整如何重塑整个医疗保健领域的供应链、采购选择、产品设计策略和采购趋势

美国关税的实施和调整将于2025年生效，这将对餵食管製造商、经销商和医疗保健机构产生多方面的影响。关税调整将改变整个供应链的成本结构，影响聚氨酯、聚氯乙烯和硅胶等常用聚合物的原料采购决策，并促使采购团队重新评估供应商多元化和近岸外包策略。这些成本压力将促使奖励优化製造地、重新谈判供应商合同，并专注于增强供应链韧性，以确保医疗机构医疗设备的稳定供应。

深度分割分析揭示了导管类型、材质、最终用户、年龄层和通路如何决定临床选择和商业策略。

细分市场分析揭示了不同设备类型、材质、最终用户、年龄层和通路之间的细微差别，这些因素都会导致不同的临床和商业性考虑。就导管类型而言，胃造瘻管包括腹腔镜辅助胃造瘻术、经皮视镜胃造瘻术和放射引导下胃造瘻术等亚型，这些亚型在插入环境、对影像诊断的依赖程度以及对临床医生培训的要求方面存在差异。同时，空肠造瘻术包括直接空肠造瘻术和经皮视镜空肠造瘻术，其选择取决于病患的生理状况和营养目标。鼻十二指肠管和鼻胃管仍然是短期肠内营养的重要途径，但与外科手术或放射引导下置入的导管相比，它们在耐受性和移位风险方面具有不同的特征。

美洲、欧洲、中东和非洲以及亚太地区的区域差异影响着经肠营养产品的监管、采购和医疗保健服务重点。

区域趋势差异显着，美洲、欧洲、中东和非洲地区以及亚太地区在法规环境、医疗服务模式和采购惯例方面存在明显差异。在美洲，完善的急诊基础设施以及不断扩展的门诊和居家医疗能力，催生了对可在医院和社区环境中植入的医疗器材的需求。该地区的政策框架和报销趋势正在影响资本采购週期，奖励企业采购能够缩短住院时间和降低再入院风险的医疗器材。

主要企业的策略重点在于产品创新、综合服务、医疗专业人员培训和分销模式，以确保可持续的采购伙伴关係。

公司层面的活动反映了以产品创新、服务整合和通路优化为核心的多面向竞争。主要企业正投资于流程培训、医护人员支援和数位化工具，以期在治疗效果而非价格方面脱颖而出。同时，小规模的专业製造商则专注于满足特定的临床需求，例如儿童尺寸或先进的固定係统。医疗设备製造商与服务供应商之间的策略联盟正在兴起，这些联盟涵盖包装插入服务、远端监测和维护通讯协定，旨在降低併发症发生率并提高患者满意度。

为实现持续的临床和采购价值，提供协调设备设计、临床医生教育、供应链韧性和商业策略的实用建议。

针对行业领导者的具体建议强调，产品设计、临床支援和商业模式应务实地协调一致，以满足不断变化的相关人员的需求。首先，应优先开发兼顾临床医师效率和病患舒适度的器械，采用生物相容性和耐用性俱佳的材料，并考虑模组化设计，以便在供应紧张时进行组件级替换。此外，还应透过全面的临床医生培训计划、基于模拟的认证以及清晰的术后护理路径来配合器械投资，从而降低併发症发生率并增强临床信心。

调查方法将采用严格的混合方法，结合临床访谈、文献综述、监管审查和供应链分析，以检验研究结果。

本调查方法采用混合方法，结合一手访谈、临床文献综述、法规审查和供应链分析，以全面了解经皮鼻饲管的现况。一手研究包括对急诊、门诊和居家照护机构的临床医生、医院和长期护理机构的采购主管以及医疗设备製造商和分销商的高管进行结构化访谈，以深入了解临床应用、采购标准和运营限制。这些定性研究结果与同行评审的临床研究和法规指南进行检验，以确保其与实践趋势和实证最佳实践相符。

一份权威的综合报告，重点阐述了创新、供应链韧性和精准策略如何协同作用，从而改善临床疗效和采购成功率。

总之，经皮经肠营养管领域正处于临床创新、医疗服务转型和采购趋势变化的交会点。技术和材料科学的进步使得更安全、更人性化的选择成为可能，从而支持向门诊和居家照护环境的过渡。同时，关税和供应链压力促使采购和生产方面进行策略调整。按管型、材质、最终用户、年龄层和分销管道进行细分，凸显了根据特定临床和采购需求客製化产品特性和商业性策略的重要性。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 按管型分類的侵入性餵食管市场

  • 胃造瘻术
    • 腹腔镜辅助胃造口术
    • 经皮视镜胃造瘻术
    • 放射线引导下胃造瘻术
  • 空肠瘻管
    • 直接空肠造口手术
    • 经皮视镜空肠造口术
  • 鼻十二指肠餵食管
  • 鼻胃管

9. 按材料分類的侵入式餵食管市场

  • 聚氨酯
  • 聚氯乙烯
  • 硅酮

第十章 依最终用户分類的侵入式餵食管市场

  • 门诊手术中心
  • 居家医疗
  • 医院
  • 专科诊所

第十一章 依年龄组别分類的侵入性餵食管市场

  • 成人版
  • 老年人
  • 儿童

12. 按分销管道分類的侵入式餵食管市场

  • 离线
  • 在线的

13. 各地区侵入性餵食管市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 依组别分類的侵入性餵食管市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国侵入性餵食管市场概况

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

16. 美国侵入式餵食管市场

第十七章：中国侵入式餵食管市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Amsino International, Inc.
  • Angiplast Private Limited
  • Applied Medical Technology, Inc.
  • Avanos Medical, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Medical LLC
  • Danone SA
  • Fresenius Kabi AG
  • Medela AG
  • Medinova Endosys Pvt. Ltd.
  • Moog, Inc.
  • Nestle Health Science SA
  • Poly Medicure Limited
  • Romsons Group
  • Vesco Medical
  • Vygon SA
Product Code: MRR-7B550E008DE2

The Invasive Feeding Tube Market was valued at USD 1.85 billion in 2025 and is projected to grow to USD 1.94 billion in 2026, with a CAGR of 5.40%, reaching USD 2.68 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.85 billion
Estimated Year [2026] USD 1.94 billion
Forecast Year [2032] USD 2.68 billion
CAGR (%) 5.40%

A definitive introduction framing invasive feeding tube technologies, clinical decision pathways, and the multidisciplinary care continuum shaping patient outcomes

This executive summary introduces the invasive feeding tube landscape by framing the technologies, clinical indications, and stakeholder responsibilities that define contemporary care delivery. The narrative begins with an overview of device types and materials, emphasizes the clinical contexts in which enteral access is chosen, and clarifies the roles of multidisciplinary teams from surgical specialists to home care coordinators. By establishing these fundamentals upfront, readers gain a concise orientation that links device attributes to procedural selection and patient outcomes.

Transitioning from fundamentals to context, the introduction also highlights how procedural techniques and care settings influence both short-term clinical success and long-term patient quality of life. It outlines the typical patient pathways for tube insertion, maintenance, and transition between acute, long-term, and home environments. This orientation primes decision-makers to appreciate the interplay between technology design, clinical workflow, and reimbursement environment, setting the stage for more detailed sections that analyze shifting market dynamics, tariff impacts, segmentation nuances, regional variations, and actionable recommendations for stakeholders.

Transformative clinical, material, and care delivery shifts that are redefining procedural choices, device design priorities, and provider procurement behaviors in enteral access

The landscape for invasive feeding tubes is experiencing transformative shifts driven by clinical innovation, regulatory scrutiny, and changing care delivery models. Advances in minimally invasive techniques and device ergonomics are making gastrostomy and jejunostomy procedures safer and more accessible in a broader range of settings, while improvements in materials such as polyurethane and silicone are addressing both biocompatibility and longevity concerns. Simultaneously, heightened focus on patient-centered outcomes has accelerated adoption of protocols that emphasize reduced complication rates and streamlined transitions from hospital to home care.

Beyond clinical and material innovations, regulatory frameworks and procurement behaviors are evolving in ways that favor standardized training, validated insertion techniques, and robust post-procedural support. These shifts are prompting manufacturers to rethink design-for-serviceability and to invest in clinician education and remote support capabilities. Concurrently, the growth of ambulatory surgical centers and home healthcare services is reshaping where enteral access is provided, creating demand for devices optimized for outpatient insertion and simplified maintenance. Together, these forces are reallocating value across stakeholders and redefining competitive priorities for product developers, healthcare providers, and payers.

How adjusted United States tariffs in 2025 are reshaping supply chains, sourcing choices, product engineering strategies, and procurement dynamics across the care continuum

In 2025 the imposition and recalibration of United States tariffs will have multilayered implications for manufacturers, distributors, and care providers involved with invasive feeding tubes. Tariff adjustments alter cost structures across the supply chain, influencing raw material sourcing decisions for common polymers such as polyurethane, polyvinyl chloride, and silicone, and prompting procurement teams to reassess supplier diversification and nearshoring strategies. These cost pressures create operational incentives to optimize manufacturing footprints, to renegotiate supplier contracts, and to increase emphasis on supply chain resilience in order to maintain consistent device availability across care settings.

Concurrently, tariff-driven changes may catalyze product-level responses such as reengineering device components to reduce reliance on taxed inputs, or accelerating the adoption of locally produced alternatives where feasible. For healthcare providers, particularly hospitals and long-term care facilities that operate within constrained budgets, these shifts can influence purchasing cycles and vendor consolidation decisions. In turn, distributors and original equipment manufacturers may respond by enhancing bundled service offerings, extending payment terms, or emphasizing value-based outcomes that justify incremental cost. Importantly, policy-induced cost dynamics reinforce the need for transparent total-cost-of-ownership conversations between suppliers and health systems, and for strategic planning that anticipates regulatory and trade volatility.

Deep segmentation analysis revealing how tube type, material, end user, age group, and distribution pathways together determine clinical selection and commercial strategy

Segmentation insights reveal nuanced dynamics across device types, materials, end users, age groups, and distribution channels, each of which drives distinct clinical and commercial considerations. Within tube type, gastrostomy devices encompass laparoscopic assisted gastrostomy, percutaneous endoscopic gastrostomy, and radiologically inserted gastrostomy subtypes that differ in insertion setting, imaging reliance, and clinician training requirements, while jejunostomy options include both direct jejunostomy and percutaneous endoscopic jejunostomy pathways that are selected based on patient physiology and nutritional goals. Nasoduodenal and nasogastric tubes remain essential for short-term enteral access but present distinct tolerability and displacement risk profiles compared with surgically or radiologically inserted devices.

Material selection also profoundly affects performance and clinical preference, with polyurethane and silicone favored for their flexibility and biocompatibility and polyvinyl chloride used where cost and stiffness considerations dominate. End user segmentation highlights divergent procurement and utilization patterns between ambulatory surgical centers, home healthcare providers, hospitals-including community, secondary care, and tertiary care hospitals-long term care facilities, and specialty clinics, each setting imposing unique requirements for device robustness, clinician skillsets, and aftercare infrastructure. Age group distinctions across adult, geriatric, and pediatric cohorts necessitate design adaptations for size, anchoring, and tolerability, and distribution channels ranging from direct sales through original equipment manufacturers and third party distributors to hospital pharmacies, online pharmacies, and retail pharmacies shape availability, pricing, and the buyer journey. Together, these segmentation layers inform targeted product development, tailored training programs, and differentiated commercial strategies that align device attributes with real-world clinical and procurement demands.

Regional differentiation across the Americas, Europe Middle East & Africa, and Asia-Pacific shaping regulatory, procurement, and care delivery priorities for enteral access products

Regional dynamics vary considerably and meaningful differentiation emerges when contrasting the Americas, Europe, Middle East & Africa, and Asia-Pacific in terms of regulatory environments, care delivery models, and procurement practices. The Americas exhibit robust acute care infrastructure with growing outpatient and homecare capabilities, creating demand for devices optimized for both hospital and community-based insertion. Policy frameworks and reimbursement trends in this region influence capital procurement cycles and create incentives for devices that reduce length of stay and readmission risks.

Europe, the Middle East & Africa present a heterogeneous landscape where regulatory harmonization in some markets contrasts with fragmented procurement in others, and where public health priorities shape adoption curves. In parts of EMEA, constrained budgets and a larger public healthcare footprint drive emphasis on cost-effective, durable devices and centralized purchasing. The Asia-Pacific region displays rapid hospital expansion, growing investment in minimally invasive procedures, and increasing local manufacturing capacity, which together accelerate uptake but also heighten price sensitivity and competition. Transitions across these regions are influenced by demographic trends such as aging populations, differential prevalence of chronic conditions requiring long-term enteral nutrition, and regional strategies to strengthen outpatient care pathways, all of which inform prioritized market approaches and regional commercialization planning.

Key company strategies emphasizing product innovation, integrated services, clinician training, and distribution models to secure durable procurement partnerships

Company-level activity reflects multifaceted competition focused on product innovation, service integration, and channel optimization. Leading firms are investing in procedural training, clinician support, and digital tools to differentiate on outcomes rather than price alone, and smaller specialized manufacturers are positioning around niche clinical needs such as pediatric sizing or advanced anchoring systems. Strategic partnerships between device producers and service providers are emerging to bundle insertion services, remote monitoring, and maintenance protocols, with an emphasis on reducing complication rates and enhancing patient satisfaction.

In parallel, commercial strategies increasingly prioritize direct engagement with hospitals and integrated delivery networks while also nurturing relationships with ambulatory surgical centers and home care organizations. Distribution models are evolving to include combinations of direct sales by original equipment manufacturers and third party distribution agreements that ensure wider geographic coverage. Companies that can demonstrate robust clinician training programs, validated safety profiles, and post-market surveillance capabilities will be better positioned to secure long-term procurement contracts. Additionally, investments in local manufacturing or regional partnerships can mitigate tariff and supply chain risks, enabling more resilient service delivery across diverse healthcare ecosystems.

Practical recommendations for aligning device design, clinician education, supply chain resilience, and commercial strategy to capture sustained clinical and procurement value

Actionable recommendations for industry leaders emphasize pragmatic alignment of product design, clinical support, and commercial models to address evolving stakeholder priorities. First, prioritize developing devices that balance clinician ergonomics with patient comfort, leveraging materials that optimize biocompatibility and durability while considering modular design to enable component-level substitution when supply constraints arise. Complement device investments with comprehensive clinician training programs, simulation-based credentialing, and clear post-procedural care pathways to lower complication rates and to build clinical trust.

Second, strengthen supply chain resilience by diversifying sourcing, evaluating nearshoring options, and building contingency inventories for critical components. Engage procurement teams proactively to create value-based contracting frameworks that link device selection to measurable clinical outcomes. Third, tailor go-to-market approaches by aligning distribution strategies to end user needs-direct sales and OEM partnerships for large hospital systems, and streamlined packaging and remote support for ambulatory and home care settings. Finally, invest in regional intelligence and localized partnerships to navigate regulatory nuances across the Americas, Europe, Middle East & Africa, and Asia-Pacific, thereby reducing market entry friction and enhancing responsiveness to tariff or policy shifts. Implementing these steps will position organizations to deliver clinical value while maintaining commercial agility.

A rigorous mixed-methods research approach combining primary clinical interviews, literature synthesis, regulatory review, and supply chain mapping to validate findings

The research methodology integrates a mixed-methods approach combining primary interviews, clinical literature synthesis, regulatory review, and supply chain analysis to construct a robust view of the invasive feeding tube environment. Primary research included structured interviews with clinicians across acute, ambulatory, and home care settings, procurement leaders in hospitals and long term care facilities, and executives from device manufacturers and distributors to capture perspectives on clinical use, purchasing considerations, and operational constraints. These qualitative insights were triangulated with peer-reviewed clinical studies and regulatory guidance to ensure alignment between practice trends and evidence-based best practices.

Supplementing the primary and literature work, the methodology incorporated an examination of material science literature to assess polymer performance attributes and a review of trade and policy documents to identify recent tariff and procurement developments. Supply chain mapping exercises traced common sourcing pathways for key components, and comparative analyses across regions elucidated how regulatory, demographic, and care delivery differences shape adoption. Throughout the process, data quality checks and respondent triangulation were applied to validate findings and to ensure that conclusions reflect widely observed patterns rather than isolated anecdotes.

A conclusive synthesis highlighting how innovation, supply chain resilience, and targeted strategies converge to improve clinical outcomes and procurement success

In conclusion, the invasive feeding tube sector sits at the intersection of clinical innovation, care delivery transformation, and shifting procurement dynamics. Advances in procedural techniques and material science are enabling safer, more patient-friendly options that support transitions into outpatient and home care environments, while tariff and supply chain pressures are prompting strategic adjustments in sourcing and manufacturing. Segmentation by tube type, material, end user, age group, and distribution channel underscores the importance of tailoring product features and commercial approaches to specific clinical and procurement needs.

Looking ahead, organizations that integrate strong clinician education programs, resilient supply chains, and targeted regional strategies will be best positioned to deliver measurable clinical value and to capture sustainable commercial opportunity. The convergence of innovation and operational discipline offers a pathway to reduce complications, improve patient experiences, and align product economics with stakeholder expectations. Stakeholders that proactively adapt to these realities-by refining device design, strengthening post-market support, and optimizing distribution models-will contribute to improved patient outcomes and to more efficient care delivery across diverse healthcare settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Invasive Feeding Tube Market, by Tube Type

  • 8.1. Gastrostomy
    • 8.1.1. Laparoscopic Assisted Gastrostomy
    • 8.1.2. Percutaneous Endoscopic Gastrostomy
    • 8.1.3. Radiologically Inserted Gastrostomy
  • 8.2. Jejunostomy
    • 8.2.1. Direct Jejunostomy
    • 8.2.2. Percutaneous Endoscopic Jejunostomy
  • 8.3. Nasoduodenal
  • 8.4. Nasogastric

9. Invasive Feeding Tube Market, by Material

  • 9.1. Polyurethane
  • 9.2. Polyvinyl Chloride
  • 9.3. Silicone

10. Invasive Feeding Tube Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Home Healthcare
  • 10.3. Hospitals
  • 10.4. Specialty Clinics

11. Invasive Feeding Tube Market, by Age Group

  • 11.1. Adult
  • 11.2. Geriatric
  • 11.3. Pediatric

12. Invasive Feeding Tube Market, by Distribution Channel

  • 12.1. Offline
  • 12.2. Online

13. Invasive Feeding Tube Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Invasive Feeding Tube Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Invasive Feeding Tube Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Invasive Feeding Tube Market

17. China Invasive Feeding Tube Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Amsino International, Inc.
  • 18.7. Angiplast Private Limited
  • 18.8. Applied Medical Technology, Inc.
  • 18.9. Avanos Medical, Inc.
  • 18.10. B. Braun Melsungen AG
  • 18.11. Becton, Dickinson and Company
  • 18.12. Boston Scientific Corporation
  • 18.13. Cardinal Health, Inc.
  • 18.14. Cook Medical LLC
  • 18.15. Danone S.A.
  • 18.16. Fresenius Kabi AG
  • 18.17. Medela AG
  • 18.18. Medinova Endosys Pvt. Ltd.
  • 18.19. Moog, Inc.
  • 18.20. Nestle Health Science S.A.
  • 18.21. Poly Medicure Limited
  • 18.22. Romsons Group
  • 18.23. Vesco Medical
  • 18.24. Vygon SA

LIST OF FIGURES

  • FIGURE 1. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INVASIVE FEEDING TUBE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL INVASIVE FEEDING TUBE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES INVASIVE FEEDING TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA INVASIVE FEEDING TUBE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY LAPAROSCOPIC ASSISTED GASTROSTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY LAPAROSCOPIC ASSISTED GASTROSTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY LAPAROSCOPIC ASSISTED GASTROSTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY PERCUTANEOUS ENDOSCOPIC GASTROSTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY PERCUTANEOUS ENDOSCOPIC GASTROSTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY PERCUTANEOUS ENDOSCOPIC GASTROSTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY RADIOLOGICALLY INSERTED GASTROSTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY RADIOLOGICALLY INSERTED GASTROSTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY RADIOLOGICALLY INSERTED GASTROSTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY DIRECT JEJUNOSTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY DIRECT JEJUNOSTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY DIRECT JEJUNOSTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY PERCUTANEOUS ENDOSCOPIC JEJUNOSTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY PERCUTANEOUS ENDOSCOPIC JEJUNOSTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY PERCUTANEOUS ENDOSCOPIC JEJUNOSTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY NASODUODENAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY NASODUODENAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY NASODUODENAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY NASOGASTRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY NASOGASTRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY NASOGASTRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY POLYVINYL CHLORIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY POLYVINYL CHLORIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY POLYVINYL CHLORIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS INVASIVE FEEDING TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA INVASIVE FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA INVASIVE FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA INVASIVE FEEDING TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE INVASIVE FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST INVASIVE FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA INVASIVE FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC INVASIVE FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN INVASIVE FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. GCC INVASIVE FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GCC INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. GCC INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, 2018-2032 (USD MILLION)
  • TABLE 149. GCC INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, 2018-2032 (USD MILLION)
  • TABLE 150. GCC INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 151. GCC INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. GCC INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. GCC INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION INVASIVE FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS INVASIVE FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 170. G7 INVASIVE FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. G7 INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. G7 INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, 2018-2032 (USD MILLION)
  • TABLE 173. G7 INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, 2018-2032 (USD MILLION)
  • TABLE 174. G7 INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 175. G7 INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. G7 INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. G7 INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. NATO INVASIVE FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. NATO INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. NATO INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, 2018-2032 (USD MILLION)
  • TABLE 181. NATO INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, 2018-2032 (USD MILLION)
  • TABLE 182. NATO INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 183. NATO INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. NATO INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 185. NATO INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES INVASIVE FEEDING TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA INVASIVE FEEDING TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)